NCT01021501 - Clinical Trial References

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Citation(s)

Kojima M, Taniguchi M, Sato K, Ueda R, Dohi Y
Antihypertensive effects of long-acting calcium channel blockers on hemodialysis days--a randomized crossover trial between benidipine and nifedipine CR. Nephron Clin Pract. 2004;97(2):c49-53.
Martre H, Sari R, Taburet AM, Jacobs C, Singlas E
Haemodialysis does not affect the pharmacokinetics of nifedipine. Br J Clin Pharmacol. 1985 Aug;20(2):155-8.

the Effect of Nifedipine Controlled Release Tablets in Hypertensive Patients on Chronic Maintenance Hemodialysis and the Influence of Hemodialysis on the Plasma Concentration of Nifedipine

Details for clinical trial NCT01021501

Clinical trial NCT01021501 - References